‘Chicago Med’ Showrunners Diane Frolov and Andy Schneider to Step Down After Nine Seasons: ‘It’s Time for Us to Move On’

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

More changes are coming at “Chicago Med.” Co-showrunners Diane Frolov and Andy Schneider will exit the show at the end of the current ninth season.

“We were honored to be chosen by Dick Wolf to run ‘Chicago Med’ and have tremendously enjoyed our association with Wolf Entertainment and Universal Television. We love ‘Chicago Med’ and have devoted all our creative energies to it, but after nine seasons we feel it’s time for us to move on and explore other possibilities,” the pair said in a statement on Tuesday. “We’ve been privileged to work with a great writing staff, production team and a brilliant cast of actors. We will miss them all.”

More from Variety

Creator and executive producer Dick Wolf added, “We’re grateful to Diane and Andy for nine fabulous seasons of ‘Chicago Med.’ They helped us give NBC a No. 1 bonafide hit for almost a decade.”

“Chicago Med,” produced by Wolf Entertainment and Universal Television, is a top series for NBC, continuously winning its Wednesday time slot with an average of more than 10.5 million viewers. The third of the “One Chicago” franchise after “Chicago Fire” and “Chicago P.D.,” it debuted in 2015.

The show underwent a great deal of changes last season with the exits of Guy Lockard, Asjha Cooper and original series stars Brian Tee and Nick Gehlfuss. This season has welcomed two new actors, Luke Mitchell and Sophia Ali.

As in most medical procedurals, there have been many changes in cast through the years. S. Epatha Merkerson (as Sharon Goodwin), Oliver Platt (as Dr. Daniel Charles) and Marlyne Barrett (as Maggie Lockwood) are the only three original stars to remain.

Best of Variety

Sign up for Variety’s Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.